BACKGROUND: We assessed the effects of protamine overdosing on thrombelastometry, bleeding, and transfusions in patients after cardiopulmonary bypass (CPB). METHODS: In group 1 (n = 15), representing the clinical standard, the protamine dose was based on the initial heparin dose, and group 2 (n = 15) received protamine based on the heparin concentration measured after CPB. Primary end points were thromboelastometric parameters. Secondary end points were perioperative blood loss and utilization of blood products. RESULTS: During CPB, heparin concentrations decreased by 40%, resulting in overdosing of protamine in group 1. Thromboelastometry revealed longer clotting time (CT) in group 1 (P values < .05). Four patients in group 1 but none in group 2 had excessive prolonged CT values (>360 seconds) and concomitant microvascular bleeding, requiring substantial replacement of coagulation factors. CONCLUSIONS:Heparin dose-based protamine management leads to protamine overdosing with inhibition of the coagulation process. Protamine management guided by heparin concentration avoids these complications.
RCT Entities:
BACKGROUND: We assessed the effects of protamine overdosing on thrombelastometry, bleeding, and transfusions in patients after cardiopulmonary bypass (CPB). METHODS: In group 1 (n = 15), representing the clinical standard, the protamine dose was based on the initial heparin dose, and group 2 (n = 15) received protamine based on the heparin concentration measured after CPB. Primary end points were thromboelastometric parameters. Secondary end points were perioperative blood loss and utilization of blood products. RESULTS: During CPB, heparin concentrations decreased by 40%, resulting in overdosing of protamine in group 1. Thromboelastometry revealed longer clotting time (CT) in group 1 (P values < .05). Four patients in group 1 but none in group 2 had excessive prolonged CT values (>360 seconds) and concomitant microvascular bleeding, requiring substantial replacement of coagulation factors. CONCLUSIONS:Heparin dose-based protamine management leads to protamine overdosing with inhibition of the coagulation process. Protamine management guided by heparin concentration avoids these complications.
Authors: Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon Journal: J Extra Corpor Technol Date: 2018-03
Authors: Vladimir Radulovic; Anna Laffin; Kenny M Hansson; Erika Backlund; Fariba Baghaei; Anders Jeppsson Journal: PLoS One Date: 2015-07-02 Impact factor: 3.240
Authors: J A Peterson; S A Maroney; W Zwifelhofer; J P Wood; K Yan; R S Bercovitz; R K Woods; A E Mast Journal: J Thromb Haemost Date: 2018-08-16 Impact factor: 5.824
Authors: Francesco De Simone; Pasquale Nardelli; Margherita Licheri; Giovanna Frau; Martina Baiardo Redaelli; Fabrizio Monaco; Alberto Zangrillo; Giovanni Landoni Journal: Ann Card Anaesth Date: 2021 Apr-Jun